~~<i id='0000CAB5E2'><strike id='0000CAB5E2'><tt id='0000CAB5E2'><pre id='0000CAB5E2'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：hotspot 2025-09-28 12:25:15 Page View：6

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novo Nordisk testing Wegovy against alcohol
Next article： Novavax promises a turnaround & Lilly roils the obesity market

explore

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Boston hospital trains restaurant workers on naloxone for overdoses

AlexHogan/STATBOSTON— ThetablessetupneartheentranceoftheBigNightLiveconcertvenuelookedlikeatypicalme

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

As AI regulations shape up, health tech startups beg for clarity

AdobeThefederalgovernment’splantoboostitsoversightoftheuseofartificialintelligencetoolsinhealthcared